The Effects of Isotonic and Hypertonic Saline Infusion on Renal Biomarkers in Healthy Young Subjects
NCT ID: NCT01414088
Last Updated: 2013-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2011-04-30
2012-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to identify and measure the activity in the water and sodium channels by measuring urine biomarkers/proteins in young healthy subjects.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Hypertonic Sodium Chloride on Urinary Biomarkers in Healthy Subjects and Patients With Chronic Kidney Disease
NCT01623661
The Effect of Thiazide, Amiloride and Hypertonic Saline on Urinary Biomarkers in Healthy Subjects
NCT01635231
Saline Infusion Test in Hyponatremia
NCT06498856
Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease
NCT01918488
Measurement of Sweat Sodium Concentration in Patients With Chronic Kidney Disease
NCT06354842
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects will be examined on three examination days. Four days prior to the examination days the subjects will consume a standard diet based on the amount of sodium and calories.
On the examination day subjects are randomised to an infusion with either isotonic saline 23 ml/kg, hypertonic saline 7 ml/kg or glucose 23 ml/kg for a period of 50 minutes.
Renal function is measured by renal clearance of 51Cr-EDTA, urinary sodium, potassium and creatinine.
Urinary NCC, NKCC and ENAC will be measured to evaluate the activity of sodium channels in the nephron.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
glucose
glucose 5 %
glucose 5%
infusion, 23 ml/kg, during 50 minutes
isotonic saline
isotonic saline 0.9 mg/ml
isotonic saline 0,9 mg/ml
infusion, 23 ml/kg, during 50 minutes
hypertonic saline
hypertonic saline 2.9 mg/ml
hypertonic saline 2,9 mg/ml
infusion, 7 ml/kg, during 50 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
isotonic saline 0,9 mg/ml
infusion, 23 ml/kg, during 50 minutes
hypertonic saline 2,9 mg/ml
infusion, 7 ml/kg, during 50 minutes
glucose 5%
infusion, 23 ml/kg, during 50 minutes
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18-45
* BMI range 18,5-30,0 kg/m2
Exclusion Criteria
* history or clinical significant signs of heart, lung, liver, kidney, endocrine, brain or neoplastic disease.
* alcohol abuse
* drug abuse
* smoking
* pregnancy or nursing
* blood donation within a month prior to examination
* Medical treatment apart from oral contraception
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Regional Hospital Holstebro
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erling Bjerregaard Pedersen
DMSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erling B Pedersen, Professor
Role: STUDY_DIRECTOR
Medicinsk Forskning, Regionshospitalet i Holstebro
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medicinsk Forskning, Regionshospitalet i Holstebro
Holstebro, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jensen JM, Mose FH, Bech JN, Nielsen S, Pedersen EB. Effect of volume expansion with hypertonic- and isotonic saline and isotonic glucose on sodium and water transport in the principal cells in the kidney. BMC Nephrol. 2013 Sep 26;14:202. doi: 10.1186/1471-2369-14-202.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EBP-JMJ-2011-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.